Sarcoma

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

Dana Vaughns and his colleagues rode 3,000 miles across the U.S. in support of funding research for the V Foundation.

Where does hope lie when it comes to improving the treatment landscape for rare cancers?

A new drug can break the circuit of cancer-causing effects that develop when certain genes fuse.

From hereditary cancer risk among twins to study findings in squamous cell carcinoma, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved Turalio to treat patients diagnosed with a group of rare, benign tumors.

The Food and Drug Administration granted a priority review to a new drug application for the accelerated approval of tazemetostat to treat metastatic or locally advanced epithelioid sarcoma not eligible for curative surgery.

From today’s top performers and athletes to surprising findings about prostate cancer treatment, here’s what is making headlines in the cancer space this week.

The FDA’s Oncologic Drugs Advisory Committee voted in favor of the agency approving pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor – a rare, benign lesion that can be locally aggressive and often recurring.

The New York City chef dreamed of opening her own restaurant.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

Nicholas J. Vogelzang, M.D., FASCO, FACP, has seen cancer through a variety of lenses – from oncologist to patient as well as caregiver – giving him a different perspective than most.

Research continues to drive the oncology field.

New clinical trials have oncologists excited about potential new therapies for patients.

Professional snowboarder Bibian Mentel-Spee inspires through her perseverance despite facing multiple bouts with the disease.

Recovery from cancer doesn’t just involve physical health; it often involves overcoming the financial barriers between illness and wellness that make moving forward seem impossible.

Do I really have to wear a prosthesis?

Finding out you have an illness is quite difficult.

Fighting retroperitoneal sarcoma can be like fighting a rare and giant beast.

Cancer not only affects the body, it affects the mind as well.

There are many ways to celebrate the absence of cancer.

Many survivors of Ewing sarcoma have few complications and long-term side effects later on, according to a recent study.

John E. Mullinax, M.D., discusses a chemotherapy strategy that may be able to save the limbs of some patients with sarcoma.

A phase 2 trial is showing that GPX-150 is promising for patients with soft tissue sarcoma.

Patients with certain types of sarcoma may benefit from PD-1 blockades, according to a recent study.

Dimosthenis Andreou, M.D., discussed the Euro-EWING99 trial with CURE.

Immunotherapy's role for treating sarcoma is being cemented as more agents and targets are identified.

Treatment and imaging advancements are drastically changing the landscape of sarcoma care.

A Lartruvo (olaratumab) combination received an accelerated approval from the FDA to treat patients with soft tissue sarcoma.

A recent trial presented an unexpected survival benefit for patients with high-risk soft tissue sarcoma who were on anthracycline-based neoadjuvant chemotherapy.